| Name | Avon Health Center |
|---|---|
| Location | 652 West Avon Rd, Avon, Connecticut |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 68.33% |
| Medicare ID (CCN) | 075244 |
| Legal Business Name | Avon Convalescent Home, Inc. |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1629004395 |
| Organization Name | AVON CONVALESCENT HOME, INC. |
| Doing Business As | AVON HEALTH CENTER |
| Address | 652 W Avon Rd, Avon, CT 06001 |
| Phone Number | 860-673-2521 |
News Archive
French scientists, examining the possibility of using nuclear medicine with gene therapy to fight heart diseases, reported their findings at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.
Case Comprehensive Cancer Center researchers, a research collaboration which includes University Hospitals Seidman Cancer Center and Case Western Reserve University, who last year identified new gene mutations unique to colon cancers in African Americans, have found that tumors with these mutations are highly aggressive and more likely to recur and metastasize.
NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, announces its first AccuSom Deliver partnership with SSM Center for Sleep Disorders, a service of SSM Health Care - St. Louis, making convenient, efficient Out-of-Center Sleep Testing (OCST) available to patients at seven locations throughout the area beginning October 1, 2012.
Building upon four decades of research and real world operation of electronic medical records and health information exchange, Regenstrief Institute researchers have developed, tested and are now operating innovative technologies to allow for the bi-directional flow of evidence-based medical information between clinical sources and public health organizations.
Deston Therapeutics LLC announced today that it is currently exploring its options to respond to a recent seizure of its Auralgan Otic Solution by the Federal Government and that it still believes that Auralgan is a safe and effective drug product.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
French scientists, examining the possibility of using nuclear medicine with gene therapy to fight heart diseases, reported their findings at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.
Case Comprehensive Cancer Center researchers, a research collaboration which includes University Hospitals Seidman Cancer Center and Case Western Reserve University, who last year identified new gene mutations unique to colon cancers in African Americans, have found that tumors with these mutations are highly aggressive and more likely to recur and metastasize.
NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, announces its first AccuSom Deliver partnership with SSM Center for Sleep Disorders, a service of SSM Health Care - St. Louis, making convenient, efficient Out-of-Center Sleep Testing (OCST) available to patients at seven locations throughout the area beginning October 1, 2012.
Building upon four decades of research and real world operation of electronic medical records and health information exchange, Regenstrief Institute researchers have developed, tested and are now operating innovative technologies to allow for the bi-directional flow of evidence-based medical information between clinical sources and public health organizations.
Deston Therapeutics LLC announced today that it is currently exploring its options to respond to a recent seizure of its Auralgan Otic Solution by the Federal Government and that it still believes that Auralgan is a safe and effective drug product.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.42 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.09 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 62.32 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.61 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.07 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 95.71 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 10.79 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 69.41 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.79 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 27 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.18 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.18 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.47 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 73.65 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 84.78 | 82.93 |
News Archive
French scientists, examining the possibility of using nuclear medicine with gene therapy to fight heart diseases, reported their findings at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.
Case Comprehensive Cancer Center researchers, a research collaboration which includes University Hospitals Seidman Cancer Center and Case Western Reserve University, who last year identified new gene mutations unique to colon cancers in African Americans, have found that tumors with these mutations are highly aggressive and more likely to recur and metastasize.
NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, announces its first AccuSom Deliver partnership with SSM Center for Sleep Disorders, a service of SSM Health Care - St. Louis, making convenient, efficient Out-of-Center Sleep Testing (OCST) available to patients at seven locations throughout the area beginning October 1, 2012.
Building upon four decades of research and real world operation of electronic medical records and health information exchange, Regenstrief Institute researchers have developed, tested and are now operating innovative technologies to allow for the bi-directional flow of evidence-based medical information between clinical sources and public health organizations.
Deston Therapeutics LLC announced today that it is currently exploring its options to respond to a recent seizure of its Auralgan Otic Solution by the Federal Government and that it still believes that Auralgan is a safe and effective drug product.
› Verified 2 days ago